Digested Titanium Dioxide Damaged Gut Cells in a Lab Study

A peer-reviewed laboratory study published on September 15, 2026, found that titanium dioxide nanoparticles transformed by simulated digestion trigger physical damage and cell death in a human intestinal cell model. While the European Union banned the additive (known there as E 171) in 2022 due to genotoxicity uncertainties, the U.S. Food and Drug Administration (FDA) still permits it in food products up to 1% by weight. The FDA maintains its position on safety while a 2023 petition asking it to repeal that permission remains under review. The new findings offer fresh molecular insight into how digested particles behave, but the researchers emphasize that this cell-culture mechanism has not yet been verified in living animals or humans.

Key takeaways

• On September 15, 2026, researchers published an in vitro study showing that digested titanium dioxide nanoparticles form large, protein-coated agglomerates that break down gut barrier integrity.
• The damage occurred via a newly characterized cell-death mechanism named mitoxyperilysis, which is distinct from classical pathways like apoptosis or ferroptosis.
• The European Union prohibited titanium dioxide as a food additive in 2022, whereas the U.S. FDA continues to permit it up to 1% by weight under 21 CFR 73.575.
• The study was conducted solely on cell cultures in dishes; it did not evaluate live animal or human clinical outcomes, nor did it test branded grocery items.
• On U.S. labels it may be named as titanium dioxide, but FDA rules also let colors like it be declared only as "color added" or "artificial color."

What happened

On September 15, 2026, a research team (Zhang and colleagues) published a study in Materials Today Bio (full text) examining how simulated digestion alters titanium dioxide nanoparticles and affects human intestinal cells. The investigation (DOI: 10.1016/j.mtbio.2026.103674) specifically analyzed what happens when these engineered particles pass through artificial oral, gastric, and intestinal digestive fluids before contacting human gut tissue models.

To recreate digestive transit, the scientists ran titanium dioxide nanoparticles through a static simulated digestive tract consisting of 5 minutes in an oral phase, 2 hours in a gastric phase, and 2 hours in an intestinal phase held at 37 degrees Celsius. They then exposed a human intestinal epithelial co-culture of Caco-2 and HT29-MTX cells to the resulting digesta.

The research evaluated a working concentration of 1.4 x 10^-4 mg/mL, derived from previously published physiological exposure models estimating that humans ingest between 10^12 and 10^14 fine and ultrafine particles daily. They also tested two lower concentrations (3.5 x 10^-5 and 7.0 x 10^-5 mg/mL), and cell viability fell progressively as the concentration increased. The experiments compared four groups: blank digesta, sucrose digesta (36 mg/mL sucrose, to mimic a sugary diet), titanium dioxide digesta, and titanium dioxide with sucrose.

What changed

This study looked at particles after simulated digestion, not only in their pristine form, and characterized how they change as they pass through simulated digestive fluids. The researchers observed that pristine nanoparticles, which typically exist as nanoscale aggregates, expand after simulated digestion into dense, micrometer-sized agglomerates coated in a biological corona (a layer of adsorbed molecules from the digestive fluids).

These transformed agglomerates induced severe intestinal barrier dysfunction through a distinct mode of cellular destruction that the authors termed "mitoxyperilysis." This death process operated independently of common programmed pathways like apoptosis, ferroptosis, necroptosis, or pyroptosis. Instead, the transformed mineral clusters triggered AKT/mTORC2-RhoA hyperactivation, causing the breakdown of the F-actin structural cytoskeleton.

Following that cytoskeletal collapse, the cells' mitochondria became abnormally tethered to the plasma membrane. This misplacement led to localized lipid peroxidation, which ruptured the outer cell membrane. Statistical testing via two-way ANOVA revealed that titanium dioxide had a significant main effect on reducing cell viability (P < 0.0001) and increasing lactate dehydrogenase (LDH) release (P < 0.0001), while the presence of sucrose neither produced nor alleviated the damage.

Who is affected

Titanium dioxide is a white color additive, so the question matters most where it is still allowed in food, including the United States. The paper itself does not name any foods, brands or products that contain it, and it does not estimate how much titanium dioxide any food or person delivers.

For other additives treated differently on each side of the Atlantic, see EU Warning-Label Additives Still Allowed in the US.

However, it is critical to contextualize who is represented in this specific laboratory experiment. The research team tested a laboratory-grade nanoparticle material (Sigma-Aldrich catalog number 718467), not food-grade E 171. Additionally, the study did not measure clinical outcomes in live animals or human patients, meaning direct human health effects cannot be deduced from this cell model alone.

What it means for shoppers

For American consumers shopping at grocery stores, little changes immediately on retail shelves as a direct consequence of this paper. The mineral remains lawful in domestic food manufacturing. Shoppers who prefer to limit or eliminate their intake of the colorant must rely on reading the ingredients statement on packaged goods.

Titanium dioxide is a color additive exempt from certification, so unlike Red 40 or Yellow 5 it does not carry an FD&C number. Under 21 CFR 101.22, colors of that kind may be declared by name (for example "titanium dioxide color" or "colored with titanium dioxide"), but they may also be declared only as "artificial color" or "color added." A label that does not say titanium dioxide is therefore not proof that it is absent.

For a full ingredient profile, see our guide What Is Titanium Dioxide? Uses, Safety, and Labeling. For another white color additive now before the FDA, see FDA Weighs Calcium Sulfate as a New Food Color.

The background

The regulatory status of titanium dioxide has diverged sharply across international boundaries over the past five years. On May 6, 2021, the European Food Safety Authority (EFSA) updated its safety assessment and concluded that titanium dioxide could no longer be considered safe when used as a food additive. EFSA said genotoxicity concerns could not be ruled out, so no acceptable daily intake (ADI) could be established, and noted that E 171 contains at most 50% of its particles in the nano range (under 100 nanometers).

Following that EFSA opinion, the European Commission adopted Regulation (EU) 2022/63 on January 14, 2022, amending the EU additive rules for E 171. Food products manufactured in accordance with the older rules were permitted to be placed on the European market until August 7, 2022, and could remain on sale until their expiration or durability date.

In the United States, the regulatory framework remains different. Under 21 CFR 73.575, the FDA permits titanium dioxide to safely color foods up to 1% by weight without requiring certification. A color additive petition filed on April 14, 2023 asks the FDA to repeal 21 CFR 73.575. On its titanium dioxide page, last updated March 4, 2024, the FDA says the petition is under review, and points out that available safety studies did not demonstrate genotoxicity, that National Toxicology Program bioassays did not show cancer development, and that some EFSA test materials were not representative of food-grade colorants.

What to watch next

The scientific discussion surrounding digested nanoparticles will hinge on whether independent research teams can reproduce these cellular findings in whole-animal models. The authors of the Materials Today Bio paper explicitly noted that their mechanism was investigated strictly in a cell culture model and has not yet been validated in vivo. Cell cultures lack gut microbiota, immune cell networks, and natural mucosal flow, leaving open questions about real-world physiology.

On the policy front, all eyes remain on the FDA's ongoing evaluation of the April 2023 revocation petition. The agency has not published an official timeline or final ruling on that filing. Furthermore, because the FDA's published guidance page was last updated on March 4, 2024, the agency has not formally evaluated or responded to this September 2026 laboratory release.

Funding for this new paper was provided by the Fundamental Research Program of Shanxi Province (grant 202303021211131) and the Doctoral Start-up Fund of Shanxi Province (SD2236), with the study authors declaring no competing commercial interests. As toxicologists continue to assess digestive transformation, consumers will need to rely on personal ingredient inspection.